drugset / Trial / NCT02946788

Open Label Photo-Documentation Study Of BPX-01 Minocycline Gel

NCT02946788

Phase 2 Completed 20 enrolled BioPharmX, Inc.
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This is a multi center open label study intended to provide photo documentation and time to response data for BPX-01 1 and 2% minocycline topical gel for the treatment of moderate to severe non-nodular inflammatory acne vulgarism.

Timeline

Start
2017-03-13
Primary completion
2018-06-01
Completion
2018-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Minocycline Small molecule 1 % Topical
Subject Minocycline Small molecule 2 % Topical

Indications